Quick Answer
Surgery Partners, Inc. reported Cash and Equivalents of $239.90 million for fiscal year 2025.
Surgery Partners, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $239.90M | -11.0% |
| 2024 | $269.50M | +37.6% |
| 2023 | $195.90M | -30.8% |
| 2022 | $282.90M | -27.4% |
| 2021 | $389.90M | +22.6% |
| 2020 | $317.90M | +242.9% |
| 2019 | $92.70M | -49.7% |
| 2018 | $184.30M | +5.4% |
| 2017 | $174.91M | -18.3% |
| 2017 | $214.21M | +207.3% |
| 2016 | $69.70M | +20.3% |
| 2015 | $57.93M | -22.7% |
| 2014 | $74.92M | +475.2% |
| 2013 | $13.03M | +149.0% |
| 2012 | $5.23M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $203.40M | -8.3% | -18.7% |
| June 30, 2025 | $250.10M | +17.1% | +9.1% |
| March 31, 2025 | $229.30M | +23.8% | -14.9% |
| December 31, 2024 | $269.50M | +37.6% | +21.5% |
| September 30, 2024 | $221.80M | -6.0% | +3.9% |
| June 30, 2024 | $213.50M | +20.3% | +15.3% |
| March 31, 2024 | $185.20M | -24.6% | -5.5% |
| December 31, 2023 | $195.90M | -30.8% | -17.0% |
- Surgery Partners, Inc. showed a decrease of -11.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, Surgery Partners, Inc.’s cash and equivalents has grown by 4485.2% (from $5.23 million to $239.90 million).
- The most recent figure is from Surgery Partners, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: